Literature DB >> 9000127

Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes.

M Lohrum1, K H Scheidtmann.   

Abstract

The tumor suppressor protein p53 is phosphorylated at multiple sites in the amino-terminal transactivation domain and at several sites in the carboxy-terminal region. Phosphorylation appears to modulate its DNA binding activity. Here we demonstrate that phosphorylation of p53 also modulates its transcriptional activity. Okadaic acid treatment of cells resulted in enhanced phosphorylation of p53 and concomitantly in enhanced transactivation of an mdm2 promoter-linked luciferase reporter gene. This effect was cell type specific, however, since transactivation was enhanced in rat and mouse fibroblasts but reduced in the human Saos-2 cell line. Moreover, the effect was dependent on the promoter. In rat cells transcription from the mdm2, waf1 (cip1) and bax gene promoters, and the artificial PG13 promoter was enhanced by okadaic acid treatment whereas that from the cyclin G promoter was reduced. When various phosphorylation site mutants of p53 were tested for transactivation of these promoters, they behaved differently. Amino-terminal mutants exhibited reduced transcriptional activities on mdm2, waf1 and cyclin G promoters but enhanced activities with bax and PG13 promoters. On the other hand, a mutant at the cdk phosphorylation site, A313, showed reduced activity with mdm2 and waf1 promoters but enhanced activity with the cyclin G promoter, and finally, mutant A390 exhibited enhanced activity on waf1 and bax promoters, but reduced activity on the cyclin G promoter. These results suggest that phosphorylation of p53 may have different effects on its transcriptional activity, depending on the cellular environment and the particular response element. Moreover, both, amino- and carboxy-terminal phosphorylation sites seem to be involved in modulating the DNA-binding and the transactivation activities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9000127

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53.

Authors:  D Daily; A Barzilai; D Offen; A Kamsler; E Melamed; I Ziv
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

2.  Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.

Authors:  F Janus; N Albrechtsen; U Knippschild; L Wiesmüller; F Grosse; W Deppert
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

3.  Driving p53 response to Bax activation greatly enhances sensitivity to taxol by inducing massive apoptosis.

Authors:  P De Feudis; S Vignati; C Rossi; T Mincioni; R Giavazzi; M D'Incalci; M Broggini
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

4.  The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.

Authors:  C Venot; M Maratrat; C Dureuil; E Conseiller; L Bracco; L Debussche
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

5.  Stabilization and activation of p53 are regulated independently by different phosphorylation events.

Authors:  M V Chernov; C V Ramana; V V Adler; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

6.  The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent.

Authors:  L Whitesell; P D Sutphin; E J Pulcini; J D Martinez; P H Cook
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

7.  Activation of p53 in cervical carcinoma cells by small molecules.

Authors:  S Hietanen; S Lain; E Krausz; C Blattner; D P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

8.  DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.

Authors:  S Y Shieh; Y Taya; C Prives
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

9.  Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1).

Authors:  Seiji Kondo; Ying Lu; Michael Debbas; Athena W Lin; Ildiko Sarosi; Annick Itie; Andrew Wakeham; JoAnn Tuan; Chris Saris; Gary Elliott; Weili Ma; Samuel Benchimol; Scott W Lowe; Tak Wah Mak; Sushil K Thukral
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

10.  p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).

Authors:  Tobias Schmid; Jie Zhou; Roman Köhl; Bernhard Brüne
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.